Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)
ClinicalTrials.gov study NCT03912415. IPD Sharing: NO. Countries: 4. Publications: 0.
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
ClinicalTrials.gov study NCT01357395. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05243524. IPD Sharing: NO. Countries: 3. Publications: 0.
Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers
ClinicalTrials.gov study NCT00247988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT04585958. IPD Sharing: YES. Countries: 1. Publications: 0.
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
ClinicalTrials.gov study NCT00003160. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01363947. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
ClinicalTrials.gov study NCT07136285. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT02269878. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
ClinicalTrials.gov study NCT07198217. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
ClinicalTrials.gov study NCT06646627. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platinum Rechallenge in Patients With Platinum-sensitive mTNBC
ClinicalTrials.gov study NCT02607215. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02944396. IPD Sharing: NO. Countries: 1. Publications: 0.
Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB
ClinicalTrials.gov study NCT05295212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.
ClinicalTrials.gov study NCT05130515. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC.
ClinicalTrials.gov study NCT05791097. IPD Sharing: YES. Countries: 0. Publications: 0.
Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
ClinicalTrials.gov study NCT04395079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.
ClinicalTrials.gov study NCT06614790. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT00466986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.
ClinicalTrials.gov study NCT07392658. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.